-
OPERATIONALIZING PATIENT ENGAGEMENT IN RARE DISEASE VALUE RESEARCH LESSONS FROM DISEASE-SPECIFIC USE CASES
Mar 18, 2026, 21:38 PM -
EVALUATING THE QUALITY OF CLINICAL EVIDENCE FOR DIGITAL HEALTH SOLUTIONS ACROSS FIVE THERAPEUTIC AREAS: FINDINGS FROM PHTI ASSESSMENTS
Mar 18, 2026, 21:38 PM -
SOCIAL MEDIA CONVERSATIONS ON IMMUNE CHECKPOINT INHIBITORS: TREATMENT EXPERIENCES, SAFETY, ACCESS, AND PATIENT PERSPECTIVES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SINGLE-DOSE HPV VACCINATION IN NEPAL:AN ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
VALUE SETS FOR AQOL, EQ-5D, HUI, QWB AND SF-6D: A SYSTEMATIC REVIEW OF THEIR AVAILABILITY AND CHARACTERISTICS
Mar 18, 2026, 21:38 PM -
PSYCHOSOCIAL AND SUPPORTIVE INTERVENTIONS FOR CAREGIVERS OF INDIVIDUALS WITH DEMENTIA: A SYSTEMATIC REVIEW
Mar 18, 2026, 21:38 PM -
SOCIODEMOGRAPHIC AND CLINICAL FACTORS ASSOCIATED WITH TIME TO TREATMENT INITIATION AND CARE PATHWAYS IN NON-METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) IN COLOMBIA: A REAL-WORLD EVIDENCE STUDY
Mar 18, 2026, 21:38 PM -
INCIDENCE AND COSTS OF SECONDARY STROKE EVENTS IN PATIENTS WITH ISCHEMIC STROKE OR TRANSIENT ISCHEMIC ATTACK OF NON-CARDIOEMBOLIC ORIGIN
Mar 18, 2026, 21:38 PM -
CUSTOMIZATION OF A LARGE LANGUAGE MODEL APPROACH TO CAPTURE PSA AND IMAGING DERIVED REAL-WORLD PROGRESSION EVENTS IN PROSTATE CANCER
Mar 18, 2026, 21:38 PM -
CRITICAL APPRAISAL OF PATIENT ENGAGEMENT FRAMEWORKS IN HEALTH ECONOMICS AND OUTCOMES RESEARCH (HEOR) AND HEALTH TECHNOLOGY ASSESSMENT (HTA)
Mar 18, 2026, 21:38 PM -
DEVELOPING A NOVEL PRO MEASURE IN MULTIPLE GLOBAL REGIONS AND LANGUAGES FOR KEY CONTRACEPTIVE SIDE EFFECTS
Mar 18, 2026, 21:38 PM -
SOCIO-DEMOGRAPHIC DISPARITIES IN HUMAN PAPILLOMAVIRUS VACCINATION AMONG U.S. ADULTS, BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM 2017-2022
Mar 18, 2026, 21:38 PM -
THE POTENTIAL EARLY IMPACT OF THE INFLATION REDUCTION ACT ON BUY-SIDE VALUATION METHODOLOGIES AND TRANSACTION STRUCTURING IN THE PHARMACEUTICAL INDUSTRY
Mar 18, 2026, 21:38 PM -
PSYCHOMETRIC VALIDATION OF THE QLQ-AA/PNH-54 BASED ON A POOLED DATASET OF A CLINICAL TRIAL AND TWO REAL-WORLD STUDIES OF CROVALIMAB IN PARTICIPANTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA
Mar 18, 2026, 21:38 PM -
PATHWAYS OF CARE AND ACCESS TO RIFAXIMIN POST-DISCHARGE IN MEDICARE-INSURED PATIENTS WITH OVERT HEPATIC ENCEPHALOPATHY
Mar 18, 2026, 21:38 PM -
PERFORMANCE OF ADAPTIVE SMART TAGS IN NESTED KNOWLEDGE FOR AUTOMATED EXTRACTION OF STUDY CHARACTERISTICS
Mar 18, 2026, 21:38 PM -
UNDERSTANDING STAKEHOLDER PERSPECTIVES BETWEEN ENDOVASCULAR AND HYBRID REPAIR FOR THORACIC AORTIC ANEURYSMS AND DISSECTIONS INVOLVING THE LEFT SUBCLAVIAN ARTERY
Mar 18, 2026, 21:38 PM -
COPD IN THE UNITED STATES: FACTORS AFFECTING TREATMENT PATTERNS AND UTILIZATION OF PHARMACOTHERAPY
Mar 18, 2026, 21:38 PM -
AVOIDABLE DIRECT COSTS IN PATIENTS WITH METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) TREATED WITH DAROLUTAMIDE: A REAL-WORLD EVIDENCE FROM A MULTICENTER STUDY IN COLOMBIA
Mar 18, 2026, 21:38 PM -
A HEALTH ECONOMIC AND ENVIRONMENTAL EVALUATION OF SUBCUTANEOUS PERTUZUMAB/TRASTUZUMABVERSUS INTRAVENOUS PERTUZUMAB/TRASTUZUMAB FOR HER2-POSITIVE BREAST CANCER IN DENMARK (HEREAFTER)
Mar 18, 2026, 21:38 PM
